Human Borna disease virus infection in Australia: Serological markers of infection in multi-transfused patients

APMIS

Volumn 116, Issue SUPPL. 124, 2008, Pages 89-93

  Flower, Robert L P ^a,b   Kamhieh, Sundrela ^a,b   Mclean, Loyola ^c   Bode, Liv ^d   Ludwig, Hanns ^e   Ward, Christopher M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROBERT KOCH INSTITUTE   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; EPITOPE; PROTEIN P40; VIRUS ANTIGEN; PEPTIDE; VIRUS ANTIBODY;

AUSTRALIA; BLOOD TRANSFUSION; BORNA DISEASE; BORNA DISEASE VIRUS; CONFERENCE PAPER; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; VIRUS INFECTION; WESTERN BLOTTING; ARTICLE; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; PREGNANCY;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; AUSTRALIA; BLOOD TRANSFUSION; BLOTTING, WESTERN; BORNA DISEASE; BORNA DISEASE VIRUS; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; PEPTIDES; PREGNANCY; RISK FACTORS;

EID: 50249117693     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00m17.x     Document Type: Conference Paper

References (11)

1. Tomonaga K, Kobayashi T, Ikuta K. Molecular and cellular biology of Borna disease virus infection. Microbes Infect 2002 4 : 491 500.
2. Bode L, Ludwig H. Clinical Similarities and Close Genetic Relationship of Human and Animal Borna Disease Virus. Archiv Virol 1997 13 : 167 182.
3. Bode L, Ludwig H. Borna Disease Virus Infection, a Human Mental-Health Risk. Clin Microbiol Rev 2003 16 : 534 545.
4. Bode L, Reckwald P, Severus WE, Stoyloff R, Ferszt R, Dietrich DE, et al. Borna disease virus-specific circulating immune complexes, antigenaemia, and free antibodies-the key marker triplet determining infection and prevailing in severe mood disorders. Mol Psychiatry 2001 6 : 481 491.
5. Bode L, Riegel S, Lange W, Ludwig H. Human infections with Borna disease virus: seroprevalence in patients with chronic diseases and healthy individuals. J Med Virol 1992 36 : 309 315.
6. Ludwig H, Furuya K, Bode L, Klein N, Dürrwald R, Lee DS. Biology and neurobiology of Borna disease virus (BDV), defined by antibodies, neutralisability and their pathogenic potential. Arch Virol. 1993 7 : 111 133.
7. Kamhieh S, Hodgson J, Bode L, Ludwig H, Flower RLP. No evidence of endemic Borna disease virus infection in Australian horses in contrast with endemic infection in other continents. Arch.Virol. 2006 151 : 709 719.
8. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, et al. Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression. Journal of Affective Disorders 1995 34 : 301 309.
9. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased Serum IL-6 and IL-1 Receptor Antagonist Concentrations in Major Depression and Treatment Resistant Depression. Cytokine 1997 9 : 853 858.
10. Pearce BD. Modelling the Role of Infections in the Etiology of Mental Illness. Clinical Neuroscience Research 2003 3 : 271 282.
11. Flower RLP, Rawlinson W, Bolton W, Hyland C, Kamhieh S, deLeon E, et al. Transfusion Transmitted Viral Infections - Does the "precautionary principle" apply to agents not known to be significant pathogens? Transfusion Medicine 2003 13 : 105.